Free Trial

Aesthetic Medical International Holdings Group (AIH) Competitors

$0.24
+0.07 (+41.97%)
(As of 05/24/2024)

AIH vs. CDIO, PLAG, TLIS, VINC, FLGC, TRAW, PMD, PPBT, KPRX, and MIRA

Should you be buying Aesthetic Medical International Holdings Group stock or one of its competitors? The main competitors of Aesthetic Medical International Holdings Group include Cardio Diagnostics (CDIO), Planet Green (PLAG), Talis Biomedical (TLIS), Vincerx Pharma (VINC), Flora Growth (FLGC), Traws Pharma (TRAW), Psychemedics (PMD), Purple Biotech (PPBT), Kiora Pharmaceuticals (KPRX), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "medical" sector.

Aesthetic Medical International Holdings Group vs.

Cardio Diagnostics (NASDAQ:CDIO) and Aesthetic Medical International Holdings Group (NASDAQ:AIH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, community ranking, analyst recommendations and dividends.

Aesthetic Medical International Holdings Group has a net margin of 0.00% compared to Aesthetic Medical International Holdings Group's net margin of -34,911.87%. Cardio Diagnostics' return on equity of 0.00% beat Aesthetic Medical International Holdings Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardio Diagnostics-34,911.87% -415.33% -216.10%
Aesthetic Medical International Holdings Group N/A N/A N/A

Cardio Diagnostics has a beta of 5.3, meaning that its stock price is 430% more volatile than the S&P 500. Comparatively, Aesthetic Medical International Holdings Group has a beta of -0.21, meaning that its stock price is 121% less volatile than the S&P 500.

8.1% of Cardio Diagnostics shares are owned by institutional investors. Comparatively, 2.1% of Aesthetic Medical International Holdings Group shares are owned by institutional investors. 30.0% of Cardio Diagnostics shares are owned by company insiders. Comparatively, 55.1% of Aesthetic Medical International Holdings Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cardio Diagnostics received 1 more outperform votes than Aesthetic Medical International Holdings Group when rated by MarketBeat users. Likewise, 66.67% of users gave Cardio Diagnostics an outperform vote while only 33.33% of users gave Aesthetic Medical International Holdings Group an outperform vote.

CompanyUnderperformOutperform
Cardio DiagnosticsOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Aesthetic Medical International Holdings GroupOutperform Votes
1
33.33%
Underperform Votes
2
66.67%

Aesthetic Medical International Holdings Group has higher revenue and earnings than Cardio Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$20K778.04-$8.38MN/AN/A
Aesthetic Medical International Holdings Group$682.59M0.02-$5.29MN/AN/A

In the previous week, Cardio Diagnostics had 2 more articles in the media than Aesthetic Medical International Holdings Group. MarketBeat recorded 4 mentions for Cardio Diagnostics and 2 mentions for Aesthetic Medical International Holdings Group. Cardio Diagnostics' average media sentiment score of 1.25 beat Aesthetic Medical International Holdings Group's score of 1.16 indicating that Aesthetic Medical International Holdings Group is being referred to more favorably in the news media.

Company Overall Sentiment
Cardio Diagnostics Positive
Aesthetic Medical International Holdings Group Positive

Cardio Diagnostics presently has a consensus target price of $1.35, indicating a potential upside of 96.85%. Given Aesthetic Medical International Holdings Group's higher possible upside, equities research analysts plainly believe Cardio Diagnostics is more favorable than Aesthetic Medical International Holdings Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardio Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Aesthetic Medical International Holdings Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Cardio Diagnostics beats Aesthetic Medical International Holdings Group on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIH vs. The Competition

MetricAesthetic Medical International Holdings GroupSpecialty outpatient clinics IndustryMedical SectorNASDAQ Exchange
Market Cap$11.32M$1.48B$5.00B$8.06B
Dividend YieldN/AN/A2.80%3.96%
P/E RatioN/AN/A113.2013.68
Price / Sales0.0221.392,565.9773.30
Price / Cash4.348.6732.5528.79
Price / Book2.372.244.944.40
Net Income-$5.29M-$10.04M$103.66M$213.46M
7 Day Performance-28.97%-8.47%-1.02%-0.96%
1 Month Performance-44.94%-17.40%3.33%3.10%
1 Year Performance-75.16%-39.28%5.39%7.51%

Aesthetic Medical International Holdings Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDIO
Cardio Diagnostics
1.9782 of 5 stars
$0.70
+1.4%
$1.35
+92.9%
-53.3%$15.88M$20,000.000.007Short Interest ↑
Positive News
PLAG
Planet Green
0 of 5 stars
$0.22
-4.3%
N/A-59.5%$15.86M$20.12M-0.76143Stock Split
Negative News
Gap Up
TLIS
Talis Biomedical
0.8287 of 5 stars
$8.85
+1.7%
$5.00
-43.5%
+15.4%$16.13M$348,000.00-0.2899Positive News
VINC
Vincerx Pharma
3.3112 of 5 stars
$0.72
+5.9%
$5.00
+594.8%
-60.5%$15.41MN/A-0.4042Short Interest ↓
News Coverage
Gap Up
FLGC
Flora Growth
3.2782 of 5 stars
$1.20
-2.4%
$6.00
+400.0%
-73.9%$15.38M$74.78M0.0097Short Interest ↑
Positive News
Gap Up
TRAW
Traws Pharma
0 of 5 stars
$0.65
+1.6%
N/AN/A$16.52M$230,000.00-0.7517Positive News
PMD
Psychemedics
0 of 5 stars
$2.62
+0.8%
N/A-47.8%$15.21M$22.10M-3.40116Short Interest ↓
PPBT
Purple Biotech
2.4967 of 5 stars
$0.60
+7.1%
$9.00
+1,400.0%
-58.6%$15.14MN/A-0.6520Gap Up
KPRX
Kiora Pharmaceuticals
2.0556 of 5 stars
$0.56
-3.5%
$2.00
+257.8%
-73.2%$15.08M$16M0.0012Short Interest ↓
MIRA
MIRA Pharmaceuticals
1.2129 of 5 stars
$1.02
+20.0%
N/AN/A$15.08MN/A-1.522Short Interest ↓
Gap Down

Related Companies and Tools

This page (NASDAQ:AIH) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners